| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
28,234 |
24,286 |
$1.85M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
4,932 |
4,845 |
$387K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
3,888 |
3,855 |
$315K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,053 |
2,868 |
$223K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
10,129 |
9,477 |
$203K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,092 |
2,083 |
$188K |
| 99441 |
|
1,867 |
1,821 |
$77K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,894 |
1,790 |
$70K |
| 99051 |
|
6,771 |
6,517 |
$67K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
800 |
800 |
$64K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
620 |
618 |
$54K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
4,965 |
4,937 |
$53K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
387 |
385 |
$36K |
| 99381 |
|
406 |
403 |
$32K |
| 99442 |
|
348 |
320 |
$22K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,172 |
584 |
$16K |
| 90697 |
|
793 |
793 |
$11K |
| 99382 |
|
97 |
97 |
$8K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
580 |
571 |
$7K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
534 |
532 |
$5K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
79 |
76 |
$4K |
| 99383 |
|
36 |
36 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
72 |
71 |
$3K |
| 90671 |
|
475 |
475 |
$3K |
| 90686 |
|
746 |
746 |
$2K |
| 90734 |
|
295 |
295 |
$791.86 |
| 90715 |
|
239 |
239 |
$467.07 |
| 90707 |
|
52 |
52 |
$448.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
82 |
82 |
$311.25 |
| 90655 |
|
29 |
29 |
$266.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
33 |
33 |
$165.00 |
| 90723 |
|
238 |
238 |
$0.00 |
| 90696 |
|
151 |
151 |
$0.00 |
| 90698 |
|
40 |
40 |
$0.00 |
| 90680 |
|
13 |
13 |
$0.00 |
| 90744 |
|
13 |
13 |
$0.00 |
| 90670 |
|
767 |
767 |
$0.00 |
| 90633 |
|
292 |
292 |
$0.00 |
| 90710 |
|
517 |
517 |
$0.00 |
| 90648 |
|
154 |
154 |
$0.00 |
| 90700 |
|
89 |
89 |
$0.00 |
| 90649 |
|
33 |
33 |
$0.00 |
| 90681 |
|
14 |
14 |
$0.00 |